Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vancomycin resistance in staphylococci.

K Hiramatsu1

  • 1Department of Bacteriology, Juntendo University, Tokyo, Japan. hiram@med.juntendo.ac.jp

Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|August 15, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[A case of high aged malrotation of intestine (right paraduodenal hernia) associated by ileus].

Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology·1999
Same author

Clindamycin suppresses endotoxin released by ceftazidime-treated Escherichia coli O55:B5 and subsequent production of tumor necrosis factor alpha and interleukin-1 beta.

Antimicrobial agents and chemotherapy·1999
Same author

Mismatch negativity and N2b attenuation as an indicator for dysfunction of the preattentive and controlled processing for deviance detection in schizophrenia: a topographic event-related potential study.

Schizophrenia research·1999
Same author

Primary targets of fluoroquinolones in Streptococcus pneumoniae.

Antimicrobial agents and chemotherapy·1999
Same author

A new method to prevent wound infection: a controlled clinical trial in patients with combined liver and bile duct resection.

Langenbeck's archives of surgery·1999
Same author

[Evaluation of preincisional mexiletine administration to alleviate postoperative pain].

Masui. The Japanese journal of anesthesiology·1998
Same journal

Perioperative tislelizumab for early-stage hepatocellular carcinoma: A phase II trial with integrated tumour microenvironment profiling and predictive modeling.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2026
Same journal

Tailored HER2 ECD mRNA-LNP vaccines boost CD8<sup>+</sup> T cell-mediated antitumor immunity for HER2-positive tumor suppression.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2026
Same journal

Hsa_circ_0003258 drives serine biosynthesis and docetaxel resistance in prostate cancer by enhancing IGF2BP3-mediated PSAT1 mRNA stability.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2026
Same journal

NHE6-driven endosome-autophagy axis confers proteasome inhibitor resistance in multiple myeloma.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2026
Same journal

Autophagy in thyroid cancer: Immune suppression and drug resistance.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2026
Same journal

Lactate-driven H3K18 lactylation promotes cisplatin resistance in bladder cancer via HNRNPF-Parkin mediated mitophagy.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2026
See all related articles

The emergence of vancomycin-resistant Staphylococcus aureus (VRSA) presents a significant threat. Heterogeneous resistance challenges standard antibiotic susceptibility testing for predicting vancomycin treatment effectiveness.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Clinical Pharmacy

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of hospital-acquired infections.
  • Vancomycin is a critical antibiotic for treating MRSA infections.
  • The emergence of vancomycin resistance in S. aureus (VRSA) poses a growing public health concern.

Purpose of the Study:

  • To review the historical emergence of glycopeptide resistance in staphylococci.
  • To discuss the mechanisms underlying vancomycin resistance in Staphylococcus aureus.
  • To highlight challenges in predicting vancomycin efficacy due to heterogeneous resistance.

Main Methods:

  • Literature review of scientific articles and clinical studies.
  • Analysis of resistance trends and mechanisms in Staphylococcus aureus.

Related Experiment Videos

  • Examination of the clinical implications of vancomycin resistance.

    • Main Results:

    • Vancomycin resistance in S. aureus (VRSA) has emerged as a significant threat to healthcare.
    • VRSA exhibits lower-level resistance compared to vancomycin-resistant enterococci (VRE).
    • Prevalence of heterogeneous vancomycin resistance (hVRSA) complicates susceptibility testing and treatment prediction.

    Conclusions:

    • The rise of VRSA necessitates a re-evaluation of current infection control strategies.
    • Understanding resistance mechanisms is crucial for developing effective therapeutic approaches.
    • Routine antibiotic susceptibility tests may not reliably predict vancomycin efficacy in VRSA cases.